BioMMED Service
All BioMMED service functions are provided to LSU-based investigators on a charge back basis. Typically, LSU researchers are charged only the costs of supplies, while most of the personnel costs are provided via support of participating LSU units.
|
 |
| Author: |
emily |
| Dated: |
Friday, May 08 2009 @ 08:37 AM CDT |
| Viewed: |
13,091 times |
|
A recently concluded animal study reported by Scandinavian Clinical Nutrition (SCN) was conducted at the Louisiana State University (LSU) School of Veterinary Medicine, Division of Biotechnology & Molecular Medicine (BIOMMED), which administers the NIH-funded Center on Experimental Infectious Disease Research (CEIDR). It showed promising results with regard to preventive effects and milder symptoms of H1N1 infection (Influenza type A), by documenting that mice ingesting Immulina experienced a significant reduction in both symptoms and lung tissue damage after being infected by the influenza virus H1N1, compared to placebo.
For the remainder of the article, click here.
|
| Author: |
emily |
| Dated: |
Friday, May 08 2009 @ 08:17 AM CDT |
| Viewed: |
13,661 times |
|
The LBRN program is having a Bioinformatics/Biocomputing Seminar, which will be held via Access Grid (SVM Room 3502) on Thursday, May 28, 2009 at 3pm.
Dr. John Quackenbush
Professor of Computational Biology and Bioinformatics
Dana-Farber Cancer Institute and the Harvard School of Public Health
Title: Information-integration approaches to biological discovery in high-dimensional data
Abstract: Two trends are driving innovation and discovery in biological sciences: technologies that allow holistic surveys of genes, proteins, and metabolites and a realization that biological processes are driven by complex networks of interacting biological molecules. However, there is a gap between the gene lists emerging from genome sequencing projects and the network diagrams that are essential if we are to understand the link between genotype and phenotype. ‘Omic technologies such as DNA microarrays were once heralded as providing a window into those networks, but so far their success has been limited, in large part because the high-dimensional data they produce cannot be fully constrained by the limited number of measurements and in part because the data themselves represent only a small part of the complete story. To circumvent these limitations, we have developed methods that combine ‘omic data with other sources of information in an effort to leverage, more completely, the compendium of information that we have been able to amass. Here we will present a number of approaches we have developed, including an integrated database that collects clinical, research, and public domain data and synthesizes it to drive discovery and an application of seeded Bayesian Network analysis applied to gene expression data that deduces predictive models of network response.
|
| Author: |
emily |
| Dated: |
Monday, May 04 2009 @ 10:01 AM CDT |
| Viewed: |
13,493 times |
|
GeneLab now houses Invitrogen's Countess automated cell counter. The Countess™ provides fast, easy and accurate cell counting without using a hemocytometer, eliminating the tedium and subjectivity of manual cell counting forever. Automated counting frees up your time, reduces eye strain, and minimizes subjective judgments that can lead to error. The instrument counts and calculates viability in 30 seconds. It also includes a dilution calculator. You can save data to a user-provided USB drive for later analysis. Free Countess software is available to download from Invitrogen’s website.
Please visit GeneLab's website for more information.
|
|
 |
User Functions
Don't have an account yet? Sign up as a New User
Lost your password?
BioMMED IMAGESThese are images of BioMMED laboratory personnel.
Group Pictures
Who's OnlineGuest Users: 7
|